- Home
- LRHC vs BDRX Comparison
LRHC vs BDRX Comparison
Compare LRHC & BDRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | LRHC | BDRX |
|---|---|---|
| Founded | 2004 | 2000 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7M | 2.0M |
| IPO Year | 2022 | 2015 |
Fundamental Metrics
Financial Performance| Metric | LRHC | BDRX |
|---|---|---|
| Price | $1.40 | $4.03 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 1.6M | 206.4K |
| Earning Date | 05-28-2026 | 09-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 26.17 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $69,448,786.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 118.67 | N/A |
| 52 Week Low | $0.08 | $0.60 |
| 52 Week High | $11.21 | $11.88 |
Technical Indicators
Market Signals| Indicator | LRHC | BDRX |
|---|---|---|
| Relative Strength Index (RSI) | 46.36 | 56.12 |
| Support Level | $0.44 | $3.79 |
| Resistance Level | $2.12 | $4.39 |
| Average True Range (ATR) | 0.29 | 0.37 |
| MACD | -0.08 | 0.00 |
| Stochastic Oscillator | 1.50 | 38.16 |
Price Performance
Historical ComparisonAbout LRHC La Rosa Holdings Corp.
La Rosa Holdings Corp operates in the U.S. residential real estate market. It is a holding company for agent-centric, technology-integrated, cloud-based, multi-service real estate companies. The company's business is organized based on the services it provides internally to the agents and to the public, which are residential and commercial real estate brokerage, franchising, real estate brokerage education and coaching, and property management. The company has six reportable segments, namely: Real Estate Brokerage Services (Residential), Franchising Services, Coaching Services, Property Management, Real Estate Brokerage Services (Commercial), and Title Settlement and Insurance. It derives maximum revenue from the Real Estate Brokerage Services (Residential) segment.
About BDRX Biodexa Pharmaceuticals plc
Biodexa Pharmaceuticals PLC is a clinical-stage biopharmaceutical company focused on developing a pipeline of products to treat diseases that have unmet medical needs. These include familial adenomatous polyposis (FAP), non-muscle invasive bladder cancer (NMIBC), type 1 diabetes (T1D), and rare or orphan brain cancers.